However, in patients with a suggestive personal and/or family history, a specific predisposing mutation in the breast cancer susceptibility gene-1 (BRCA1) or in the breast cancer susceptibility gene-2 (BRCA2) is identified in only fewer than 30% of cases [1]. This evidence concerns the gene BRCA2 and breast carcinoma.